<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Hydrocortisone - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Hydrocortisone</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Derm / ENT / Eye / Topicals</div>
      <h1>Hydrocortisone</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Hydrocortisone 1% Cream</li>
          <li>Hydrocortisone 100mg Injection (powder)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <p><strong>Topical (1% cream)</strong></p>
        <ul>
          <li><strong>Mild inflammatory skin conditions (eczema, dermatitis, pruritus)</strong>
            <ul>
              <li>Apply thin layer to affected area 2–4 times daily until symptoms controlled</li>
              <li>Use the lowest frequency that maintains control</li>
              <li>Limit duration to 2 weeks for facial/intertriginous areas unless directed otherwise</li>
            </ul>
          </li>
        </ul>
        <p><strong>Injectable (100 mg)</strong></p>
        <ul>
          <li><strong>Acute adrenal insufficiency / adrenal crisis (emergency)</strong>
            <ul>
              <li>100 mg IV/IM immediately, then 50–100 mg IV/IM every 6–8 hours until stable</li>
              <li>Transition to oral corticosteroids when appropriate</li>
              <li>Requires concurrent fluid resuscitation and electrolyte management</li>
            </ul>
          </li>
          <li><strong>Severe allergic reaction (adjunct; when epinephrine and antihistamines primary)</strong>
            <ul>
              <li>100–500 mg IV/IM (follow local anaphylaxis protocols)</li>
              <li>Not a substitute for epinephrine in anaphylaxis</li>
            </ul>
          </li>
          <li><strong>Severe inflammatory conditions (when IV corticosteroid indicated)</strong>
            <ul>
              <li>Dosing highly variable by condition; follow clinical protocols</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li><strong>Topical:</strong> Mild to moderate inflammatory dermatoses (eczema, contact dermatitis, pruritus, insect bites)</li>
          <li><strong>Injectable:</strong> Acute adrenal insufficiency/adrenal crisis, severe allergic reactions (adjunct), severe inflammatory/immunologic conditions requiring IV corticosteroid (provider-directed)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <p><strong>Topical:</strong></p>
        <ul>
          <li>Hypersensitivity to hydrocortisone or cream components</li>
          <li>Skin infections (fungal, bacterial, viral) unless treated concurrently (can worsen infection)</li>
          <li>Rosacea, perioral dermatitis, acne (can exacerbate)</li>
          <li>Prolonged use on face/intertriginous areas: skin atrophy risk</li>
          <li>Do not use on open wounds or eyes</li>
        </ul>
        <p><strong>Injectable:</strong></p>
        <ul>
          <li>Hypersensitivity to hydrocortisone</li>
          <li>Systemic fungal infection (relative contraindication unless treating adrenal crisis)</li>
          <li>Caution in patients with infection (can mask symptoms/signs and impair immune response)</li>
          <li>Diabetes: monitor glucose closely (hyperglycemia risk)</li>
          <li>GI ulcer risk, psychiatric symptoms, electrolyte disturbances with prolonged or high-dose use</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <p><strong>Topical:</strong></p>
        <ul>
          <li>Skin atrophy, striae (with prolonged use or occlusion)</li>
          <li>Burning, itching at application site</li>
          <li>Secondary skin infection</li>
          <li>Rarely: systemic absorption with extensive/prolonged use</li>
        </ul>
        <p><strong>Injectable:</strong></p>
        <ul>
          <li>Hyperglycemia, fluid retention</li>
          <li>Hypertension, electrolyte disturbances (hypokalemia)</li>
          <li>Mood changes, insomnia, psychosis (dose/duration dependent)</li>
          <li>Immunosuppression, increased infection risk</li>
          <li>GI upset, peptic ulcer (higher doses/prolonged use)</li>
          <li>Adrenal suppression with prolonged use (do not abruptly discontinue)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <p><strong>Topical:</strong></p>
        <ul>
          <li>Apply thin layer to clean, dry skin; rub in gently</li>
          <li>Wash hands before and after application (unless treating hands)</li>
          <li>Avoid occlusive dressings unless directed (increases absorption)</li>
          <li>Do not apply to face for prolonged periods without reassessment</li>
        </ul>
        <p><strong>Injectable:</strong></p>
        <ul>
          <li>Reconstitute 100 mg powder with provided diluent or sterile water for injection per product instructions</li>
          <li>May give IV push (over 30 seconds to several minutes) or IM injection</li>
          <li>For adrenal crisis: give immediately alongside IV fluids and management of underlying trigger</li>
          <li>Store reconstituted solution per product instructions; use promptly</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <p><strong>Topical:</strong></p>
        <ul>
          <li>Symptom improvement (itch, erythema, inflammation)</li>
          <li>Skin integrity (watch for atrophy, secondary infection, worsening)</li>
          <li>If no improvement after 2 weeks or symptoms worsen: reassess diagnosis</li>
        </ul>
        <p><strong>Injectable:</strong></p>
        <ul>
          <li>Vital signs, clinical response (especially in adrenal crisis or severe allergy)</li>
          <li>Blood glucose (especially in diabetics or prolonged use)</li>
          <li>Electrolytes, BP if prolonged therapy</li>
          <li>Watch for infection, GI bleeding, psychiatric symptoms with repeated/high doses</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <p><strong>Topical:</strong></p>
        <ul>
          <li>Good first-line for minor inflammatory skin conditions; safe for short-term use</li>
          <li>If skin infection suspected: do not use steroid alone; treat infection concurrently</li>
          <li>Avoid prolonged unsupervised use on face or intertriginous areas</li>
        </ul>
        <p><strong>Injectable:</strong></p>
        <ul>
          <li>Critical for adrenal crisis: recognize symptoms (hypotension, shock, confusion in patient with adrenal insufficiency or recent steroid withdrawal) and treat urgently with hydrocortisone + IV fluids</li>
          <li>In anaphylaxis: prioritize epinephrine; hydrocortisone is adjunctive</li>
          <li>If limited labs: monitor clinical response and blood glucose when feasible</li>
          <li>Document indication, dose, time, and response clearly; plan for evacuation if severe underlying condition</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>Health Canada product monograph (hydrocortisone cream): <a href="https://pdf.hres.ca/dpd_pm/00062011.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00062011.PDF</a></li>
          <li>Health Canada product monograph (hydrocortisone injection): <a href="https://pdf.hres.ca/dpd_pm/00045951.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00045951.PDF</a></li>
          <li>Medscape - Hydrocortisone (Topical): <a href="https://reference.medscape.com/drug/cortisone-hydrocortisone-topical-343862" target="_blank" rel="noopener">https://reference.medscape.com/drug/cortisone-hydrocortisone-topical-343862</a></li>
          <li>Medscape - Hydrocortisone (Systemic): <a href="https://reference.medscape.com/drug/cortef-hydrocortisone-systemic-343861" target="_blank" rel="noopener">https://reference.medscape.com/drug/cortef-hydrocortisone-systemic-343861</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
